Departamento de Psiquiatría, Radioloxía, Saúde Pública, Enfermaría e Medicina
Departamento
GlaxoSmithKline (United Kingdom)
Londres, Reino UnidoPublicacións en colaboración con investigadores/as de GlaxoSmithKline (United Kingdom) (9)
2021
-
Cost-effectiveness analysis of anti–IL-5 therapies of severe eosinophilic asthma in Spain
Journal of Medical Economics, Vol. 24, Núm. 1, pp. 874-882
-
Multi-level considerations for optimal implementation of long-acting injectable antiretroviral therapy to treat people living with HIV: perspectives of health care providers participating in phase 3 trials
BMC Health Services Research, Vol. 21, Núm. 1
2020
-
Patient-Reported Outcomes in ATLAS and FLAIR Participants on Long-Acting Regimens of Cabotegravir and Rilpivirine Over 48 Weeks
AIDS and Behavior, Vol. 24, Núm. 12, pp. 3533-3544
-
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicines
British Journal of Clinical Pharmacology, Vol. 86, Núm. 6, pp. 1034-1051
2019
-
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials
The Lancet, Vol. 393, Núm. 10167, pp. 143-155
2018
-
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529
2013
-
Dolutegravir plus Abacavir-Lamivudine for the treatment of HIV-1 infection
New England Journal of Medicine, Vol. 369, Núm. 19, pp. 1807-1818
2005
-
Inhibition of iNOS activity by 1400W decreases glutamate release and ameliorates stroke outcome after experimental ischemia
Neurobiology of Disease, Vol. 18, Núm. 2, pp. 375-384
2002
-
Oxidative damage and phospholipid fatty acyl composition in skeletal muscle mitochondria from mice underexpressing or overexpressing uncoupling protein 3
Biochemical Journal, Vol. 368, Núm. 2, pp. 597-603